News
![FSD Pharma to Present at the H.C. Wainwright Bioconnect Conference on January 10-13th : https://mms.businesswire.com/media/20210517005319/en/809100/5/fsd_logo_black_molecule_color.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK1NLVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--faa61f4554e215043d758441d33218ff6e1d0686/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/fsd_logo_black_molecule_color.jpg?locale=us)
FSD Pharma to Present at the H.C. Wainwright Bioconnect Conference on January 10-13th
FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced
![Sensorion appoints Aniz Girach as Independent Board Member: https://mms.businesswire.com/media/20210609005851/en/705797/5/logo-sensorion2.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK0dxVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--df3db62501cd2dac51e6a4832a420790d1de65b6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/logo-sensorion2.jpg?locale=us)
Sensorion appoints Aniz Girach as Independent Board Member
Regulatory News:
Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and
![EQS-News: Holcim completes acquisition in the US Pacific Northwest region: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23785/LafargeHolcim_logo.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBcU1CIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--dc4831c6b62be27b37a420e673523fbc6807fc40/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/LafargeHolcim_logo.png?locale=us)
EQS-News: Holcim completes acquisition in the US Pacific Northwest region
DGAP-News: GEA Group Aktiengesellschaft: A capital market information
DGAP-News: Nordex SE: Nordex Group receives an order for 380 MW in Finland
![DGAP-News: GRENKE AG: GRENKE achieves EUR 1.7 billion in new leasing business for financial year 2021, reaching the upper end of the forecast: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24105/Grenke_Logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBPdz09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--4db50f106cec03dc81a4271045bbc188ee53d7db/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Grenke_Logo.jpg?locale=us)
DGAP-News: GRENKE AG: GRENKE achieves EUR 1.7 billion in new leasing business for financial year 2021, reaching the upper end of the forecast
![Helmerich & Payne, Inc. To Participate in Virtual Conferences in January 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24508/Helmerich___Payne_logo.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBYzQ9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--6a7f9a6e08e010bc196afe244518a0e536956354/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Helmerich___Payne_logo.png?locale=us)
Helmerich & Payne, Inc. To Participate in Virtual Conferences in January 2022
Helmerich & Payne, Inc. (NYSE: HP) today announced that Mark Smith, Senior Vice President and Chief Financial Officer; Trey Adams, Senior Vice President of Digital Operations, Sales & Marketing
![KKR Real Estate Finance Trust Inc. Announces Record Annual and Fourth Quarter 2021 Originations of $4.8 Billion and $1.8 Billion, respectively: https://mms.businesswire.com/media/20191216005659/en/582992/5/02_02_17_KREF_Logo_RGB_01_300.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeXpzRnc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--02016df4f8caee9f5c3d803ec1383c4f137a14bd/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/02_02_17_KREF_Logo_RGB_01_300.jpg?locale=us)
KKR Real Estate Finance Trust Inc. Announces Record Annual and Fourth Quarter 2021 Originations of $4.8 Billion and $1.8 Billion, respectively
KKR Real Estate Finance Trust Inc. (the “Company” or “KREF”) (NYSE: KREF) today announced that it closed 18 floating-rate loans totaling approximately $1.8 billion of commitments in the fourth
![GeoPark Provides an Update on Its Board of Directors: https://mms.businesswire.com/media/20191106006113/en/700773/5/Logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMEVrRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b3e6580489ac5471ba6084190cbd13bc7f8dbb3b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Logo.jpg?locale=us)
GeoPark Provides an Update on Its Board of Directors
GeoPark Limited (“GeoPark” or the “Company”) (NYSE: GPRK), a leading independent Latin American oil and gas explorer, operator and consolidator today provides an update on its Board of Directors.
![Columbia Care Opens its 80th Dispensary with New Cannabist Location in Virginia Beach: https://mms.businesswire.com/media/20200203005819/en/720533/5/CC_CORPORATE_-01.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM2hVSVE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9aaf56e524d07c92645b5246a555901838c3aad7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/CC_CORPORATE_-01.jpg?locale=us)
Columbia Care Opens its 80th Dispensary with New Cannabist Location in Virginia Beach
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis
![ImmunoPrecise Antibodies Announces Grant of Stock Options: https://mms.businesswire.com/media/20210203005983/en/857090/5/ImmunoPrecise_logo_HZ_PMS.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeWtBVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--000b3982bf8e90eb30a01cca9649be03b0baae66/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/ImmunoPrecise_logo_HZ_PMS.jpg?locale=us)
ImmunoPrecise Antibodies Announces Grant of Stock Options
IMMUNOPRECISE ANTIBODIES LTD. (“IPA” or the “Company”) (NASDAQ: IPA) (TSXV: IPA), a leader in full-service, therapeutic antibody discovery, today announced that its board of directors has approved
![Verisign to Report Fourth Quarter and Full Year 2021 Financial Resultshttp://lemonwebhosting.com/wp-content/uploads/2013/04/logo-verisign-large.png: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12179/logo-verisign-large.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBakVDIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--4e559356c0cd0f17ca48c219c3cf363ea5618153/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/logo-verisign-large.png?locale=us)
Verisign to Report Fourth Quarter and Full Year 2021 Financial Results
VeriSign, Inc. (NASDAQ: VRSN), a global provider of domain name registry services and internet infrastructure, today announced that its earnings call for the fourth quarter and full year 2021, will
![Acadia Healthcare Announces Acquisition of CenterPointe Behavioral Health System: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMGxvTXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9495f97191ece669fac2cb2dda5975e1824b4da8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/ACHC.jpg?locale=us)
Acadia Healthcare Announces Acquisition of CenterPointe Behavioral Health System
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced the Company has completed the acquisition of CenterPointe Behavioral Health System, the largest dedicated behavioral healthcare
![Life Storage, Inc. Raises Quarterly Common Stock Dividend by 16%: https://mms.businesswire.com/media/20200102005533/en/548307/5/LSI.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN0JKR3c9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ea4e90f5ebe9a28b69cb49a651666d9e28270723/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/LSI.jpg?locale=us)
Life Storage, Inc. Raises Quarterly Common Stock Dividend by 16%
The Board of Directors of Life Storage, Inc. (NYSE:LSI), a self-storage real estate investment trust (REIT), announced today an increase in the Company’s quarterly common stock dividend from $0.86
![IFF and SleepScore Labs to Unveil Validated Scent Solutions to Support Improved Sleep at CES 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24521/International_Flavors_and_Fragrances_%28logo%29.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZ01CIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--51f91475ae75e581820ddc30e3dc8db1ebc296be/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/International_Flavors_and_Fragrances_-28logo-29.png?locale=us)
IFF and SleepScore Labs to Unveil Validated Scent Solutions to Support Improved Sleep at CES 2022
IFF (NYSE: IFF) and SleepScore Labs introduce a groundbreaking scent solution to improve sleep quality, building on the partnership initiated in 2020 and leveraging IFF’s internal Science of
![Cohu to Present at 24th Annual Needham Virtual Growth Conference: https://mms.businesswire.com/media/20191106005014/en/502601/5/Cohu_Standard_Color_Logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNFFsRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--5196160861bcfe851edf3f644043e596b892ce77/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Cohu_Standard_Color_Logo.jpg?locale=us)
Cohu to Present at 24th Annual Needham Virtual Growth Conference
Cohu, Inc. (NASDAQ: COHU), a global leader in back-end semiconductor equipment and services, today announced that management will participate at the 24th Annual Needham Virtual Growth Conference on
![MaaT Pharma to Present at H.C. Wainwright BioConnect 2022 Virtual Conference: https://mms.businesswire.com/media/20211211005036/en/729326/5/Nov_2018_new_version_MaaT_Pharma_logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK09sVnc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d25a561bb4e3c59d85340669bd72006bea493006/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Nov_2018_new_version_MaaT_Pharma_logo.jpg?locale=us)
MaaT Pharma to Present at H.C. Wainwright BioConnect 2022 Virtual Conference
Regulatory News:
MaaT Pharma (EURONEXT: MAAT - the “Company“), a French clinical-stage biotech and a pioneer in the development of microbiome-based ecosystem therapies dedicated to improving
![Interactive Brokers Group Reports Brokerage Metrics and Other Financial Information for December 2021, includes Reg.-NMS Execution Statistics: https://mms.businesswire.com/media/20191101005473/en/590270/5/logo-ib-txtblk-newswire.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBME1sRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e0775e33f75ab8da792564edbd520300943e6aaa/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/logo-ib-txtblk-newswire.jpg?locale=us)
Interactive Brokers Group Reports Brokerage Metrics and Other Financial Information for December 2021, includes Reg.-NMS Execution Statistics
Interactive Brokers Group, Inc. (Nasdaq: IBKR) an automated global electronic broker, today reported its Electronic Brokerage monthly performance metrics for December.
Brokerage highlights for
![Intevac Announces Sale of Photonics Business: https://mms.businesswire.com/media/20191101005110/en/497226/5/IVAC_LOGO_Horizontal_.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeGtqRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--db42b6df7d07d0fe0d3f25aae31922e20e7166a5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/IVAC_LOGO_Horizontal_.jpg?locale=us)
Intevac Announces Sale of Photonics Business
Intevac, Inc. (Nasdaq: IVAC), (“Intevac” or the “Company), a leading supplier of thin-film processing systems, today announced the sale of its Photonics business (“Photonics”) to EOTECH LLC, a
![ABIONYX Pharma Announces That the French Drug Safety Agency (Agence Nationale de Sécurité du Médicament or ANSM) Has Granted a Compassionate Access Authorization for the bio-HDL (CER-001) in COVID-19 Disease: https://mms.businesswire.com/media/20210302005302/en/862456/5/ABIONYX_W.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM0FtVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3f52df4b7747dcabeb26ea260ead9545699cca5c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/ABIONYX_W.jpg?locale=us)
ABIONYX Pharma Announces That the French Drug Safety Agency (Agence Nationale de Sécurité du Médicament or ANSM) Has Granted a Compassionate Access Authorization for the bio-HDL (CER-001) in COVID-19 Disease
ABIONYX Pharma (FR0012616852 – ABNX – PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies for patients, today announces that the
![Ecovyst Inc. Appoints Christopher Evans to Lead Investor Relations](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Ecovyst Inc. Appoints Christopher Evans to Lead Investor Relations
Ecovyst Inc. (NYSE: ECVT) (“Ecovyst”), a leading integrated and innovative global provider of specialty catalysts and services, today announced that it has appointed Christopher Evans to lead
![Vancouver Clinic and Humana Introduce New Primary Care Practice Designed to Enhance Medicare Advantage Experience: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBaXNCIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--3d3c39355769d1759c5221ae0bf511106538ecb5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Humana_logo.png?locale=us)
Vancouver Clinic and Humana Introduce New Primary Care Practice Designed to Enhance Medicare Advantage Experience
Vancouver Clinic and Humana have teamed up to bring additional access to patient-focused primary care to Gresham, Oregon. Enliven by Vancouver Clinic (Enliven) recently opened its doors for the
![MedMen Announces Termination of Investment Agreement: https://mms.businesswire.com/media/20191111005149/en/659546/5/Medmen.LogoHorizontalRed.Reg.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeGU1RUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b814bf6c90f88e33b106d8236ea27e17f4e41a84/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/MedmenLogoHorizontalRedReg.jpg?locale=us)
MedMen Announces Termination of Investment Agreement
MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis retailer with operations across the United States, today announced its termination of that certain
![Exelon to Host Investor and Analyst Events for Exelon and Constellation to Discuss Post-Separation Strategies: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24420/375px-Exelon_Corp_logo.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZDA9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--c13d27bfe2b2527b6b8ae01b4bd09cddb7637bbd/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/375px-Exelon_Corp_logo.png?locale=us)
Exelon to Host Investor and Analyst Events for Exelon and Constellation to Discuss Post-Separation Strategies
Exelon Corp. (Nasdaq: EXC) today announced that it will host virtual investor and analyst events to highlight the post-separation business strategies for Exelon and Constellation.
Exelon’s event
![Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Olderhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZHc9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--be1a2af5756eaa0acf5414ead3504a7e3ad45f8a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Pfizer.jpg?locale=us)
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) of a booster dose of the